PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY – Trademark Portfolio
Entity Type: 99
PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LIFETABS. The owner is based in Drogheda, County Louth.
9 Hibury, Rathmullan Road
Drogheda, County Louth , IE
Showing of trademarks Trademarks
Trademark Classifications
PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY have?
PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY file in?
PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY's most well-known trademarks?
PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY's registered trademark portfolio includes well-known marks such as LIFETABS. These are among 1 currently registered trademark in the portfolio.
What is PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY's trademark registration success rate?
PONCE DE LEON PHARMACEUTICALS DESIGNATEDACTIVITY COMPANY has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.